Braskem (BAK) EBITDA (2009 - 2025)

Braskem (BAK) has reported EBITDA for 16 consecutive years, with $77.3 million the latest figure, recorded in Q1 2025.

• Quarterly EBITDA changed N/A year-over-year to $77.3 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2.3 billion (changed N/A YoY) and the FY2025 annual result came in at -$335.2 million, down 133.82% from the prior year.
• EBITDA retreated to $77.3 million in Q1 2025 per BAK's latest filing, from $839.3 million in the prior quarter.
• Over the last five years, EBITDA for BAK reached as high as $1.0 billion in Q4 2022 and fell as low as $77.3 million in Q1 2025.
• A 4-year average of $511.9 million and a median of $505.0 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2021 — EBITDA surged 218.54% — and 2023, when it decreased 17.16%.
• Year by year, EBITDA stood at $667.4 million in 2021, then surged by 51.82% to $1.0 billion in 2022, then fell by 17.16% to $839.3 million in 2023, then sank by 90.79% to $77.3 million in 2025.
• According to Business Quant data, EBITDA over the past three periods registered $77.3 million, $839.3 million, and $342.6 million for Q1 2025, Q4 2023, and Q3 2023 respectively.